GENEVA: Some of Switzerland’s top university hospitals are teaming up to take on the soaring cost of cancer cell therapy offered by big pharma.

The hospitals are hoping to offer the treatment for between 150,000 Swiss francs (US$151,026) and 200,000 francs. That’s about one-third cheaper than the commercialized process offered by the pharmaceutical industry.

“We are convinced that such cancer therapies can be realized at significantly lower costs,” Roger von Moos, president of the Swiss Association for Clinical Cancer Research and head physician at the Chur Cantonal Hospital, told Swiss newspaper NZZ am Sonntag.

Read more at:  https://www.freemalaysiatoday.com/category/business/2019/07/28/swiss-to-take-on-big-pharma-with-cheaper-cancer-treatment/